Accordingly, reduced expression levels of RIPK3 observed in CRC patients support the idea that RIPK3 plays a pivotal role in CRC pathogenesis but further studies are needed to clarify the tumor suppressor function of RIPK3-dependent necroptosis in CRC tumorigenesis (Fig. 4a)132. This evidence concerns the gene RIPK3 and colorectal carcinoma.